FI972430A0 - Immunosuppressiivista aktiivisuutta sisältäviä monoklonaalisen vasta-aineen fragmentteja - Google Patents

Immunosuppressiivista aktiivisuutta sisältäviä monoklonaalisen vasta-aineen fragmentteja

Info

Publication number
FI972430A0
FI972430A0 FI972430A FI972430A FI972430A0 FI 972430 A0 FI972430 A0 FI 972430A0 FI 972430 A FI972430 A FI 972430A FI 972430 A FI972430 A FI 972430A FI 972430 A0 FI972430 A0 FI 972430A0
Authority
FI
Finland
Prior art keywords
fragment
monoclonal antibodies
immunosuppressive activity
antibodies containing
containing immunosuppressive
Prior art date
Application number
FI972430A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972430A (fi
Inventor
Zoltan Nagy
Damir Vidovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI972430A publication Critical patent/FI972430A/fi
Publication of FI972430A0 publication Critical patent/FI972430A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI972430A 1994-12-07 1997-06-06 Immunosuppressiivista aktiivisuutta sisältäviä monoklonaalisen vasta-aineen fragmentteja FI972430A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35091594A 1994-12-07 1994-12-07
PCT/EP1995/004648 WO1996017874A1 (en) 1994-12-07 1995-11-25 Monoclonal antibody fragments having immunosuppressant activity

Publications (2)

Publication Number Publication Date
FI972430A FI972430A (fi) 1997-06-06
FI972430A0 true FI972430A0 (fi) 1997-06-06

Family

ID=23378740

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972430A FI972430A0 (fi) 1994-12-07 1997-06-06 Immunosuppressiivista aktiivisuutta sisältäviä monoklonaalisen vasta-aineen fragmentteja

Country Status (19)

Country Link
EP (1) EP0787151A1 (no)
JP (1) JP2001506122A (no)
CN (1) CN1168679A (no)
AR (1) AR002005A1 (no)
AU (1) AU4256096A (no)
BR (1) BR9509902A (no)
CA (1) CA2206471A1 (no)
CO (1) CO4480041A1 (no)
CZ (1) CZ172497A3 (no)
FI (1) FI972430A0 (no)
HU (1) HUT77342A (no)
IL (1) IL116228A0 (no)
MA (1) MA23739A1 (no)
NO (1) NO972522L (no)
PE (1) PE52996A1 (no)
PL (1) PL320610A1 (no)
TR (1) TR199501542A2 (no)
WO (1) WO1996017874A1 (no)
ZA (1) ZA9510195B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893507A1 (en) * 1997-07-25 1999-01-27 Institut Gustave Roussy Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
AU5588099A (en) * 1998-08-28 2000-03-21 Dendreon Corporation Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody
EP1156062A1 (en) * 2000-05-12 2001-11-21 GPC Biotech AG Immunomodulatory human MHC class II antigen-binding peptides/proteins
DE60035337T2 (de) * 2000-05-12 2008-02-28 Gpc Biotech Ag Humane Peptide/Proteine, die das Töten von Zellen, einschliesslich lymphoider Tumorzellen, herbeiführen oder bewirken
US7521047B2 (en) 2000-05-12 2009-04-21 Gpc Biotech Ag Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
WO2003030831A2 (en) 2001-10-11 2003-04-17 Protein Design Labs, Inc. Treatment of prostate cancer by inhibitors of atp synthase
CN1571797A (zh) 2001-10-15 2005-01-26 麒麟麦酒株式会社 抗hla－dr抗体
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
EP2552483A4 (en) * 2010-04-01 2013-09-25 Immunomedics Inc USE OF ANTIBODIES TO REDUCE THE NUMBER OF CELLS CONTAINING ANTIGENS AND DENDRITIC CELLS
KR102647825B1 (ko) * 2021-07-22 2024-03-14 서울대학교산학협력단 항-hla-dp 단클론 항체 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068790B1 (en) * 1981-06-25 1986-02-26 The Board Of Trustees Of The Leland Stanford Junior University Allele specific immunotherapeutic method and dosage form
DE69028713T3 (de) * 1989-12-27 2004-05-13 Centocor, Inc. Schimäre immunoglobuline für cd4-rezeptoren
DK1266965T3 (da) * 1991-07-25 2006-09-25 Biogen Idec Inc Rekombinante antistoffer til human terapi

Also Published As

Publication number Publication date
MA23739A1 (fr) 1996-07-01
HUT77342A (hu) 1998-03-30
BR9509902A (pt) 1997-10-21
TR199501542A2 (tr) 1996-07-21
EP0787151A1 (en) 1997-08-06
MX9704225A (es) 1997-09-30
WO1996017874A1 (en) 1996-06-13
NO972522D0 (no) 1997-06-03
CO4480041A1 (es) 1997-07-09
JP2001506122A (ja) 2001-05-15
CN1168679A (zh) 1997-12-24
AR002005A1 (es) 1998-01-07
FI972430A (fi) 1997-06-06
CA2206471A1 (en) 1996-06-13
NO972522L (no) 1997-08-06
CZ172497A3 (en) 1997-10-15
ZA9510195B (en) 1996-06-07
AU4256096A (en) 1996-06-26
PE52996A1 (es) 1996-12-12
IL116228A0 (en) 1996-03-31
PL320610A1 (en) 1997-10-13

Similar Documents

Publication Publication Date Title
DK1516629T3 (da) Humaniseret anti-CD-11a antibodies
PT719859E (pt) Anticorpo monoclonal anti-alfa v-integrina
IL128406A0 (en) Monoclonal antibodies
DK0837927T3 (da) Anti-CD80-antistoffer
DE69319662T2 (de) Monoklonale Antikörper gegen GP130-Protein
DK666389D0 (da) Monoklonalt antistof
EP0870826A4 (en) NEW PROTEINS AND MONOCLONAL ANTIBODIES AGAINST THESE
DE69828154D1 (de) Anti-alphavbeta3 humanizierte monoklonale antikörper
FI972430A0 (fi) Immunosuppressiivista aktiivisuutta sisältäviä monoklonaalisen vasta-aineen fragmentteja
DE69738312D1 (de) Hepatitis b monoklonale antikörper
NO177311C (no) Anti-fucosylceramid monoklonalt antistoff
BR9606978A (pt) Anticorpos monoclonais antiidiótipos (ab2) e usos dos mesmos
DK413389A (da) Monoklonale antistoffer
GB9718911D0 (en) Monoclonal antibodies
DE69427850T2 (de) Monoklonaler antikörper gegen mucoglykoprotein
BR9709080A (pt) Anticorpo monoclonal anti-MP52 humano
GB9506425D0 (en) New uses of monoclonal antibodies
DE69324928T2 (de) Monoklonaler antikörper
SI0742795T1 (en) Immuno-stimulatory monoclonal antibodies
GB9615027D0 (en) Monoclonal antibodies
NO924137D0 (no) Monoklonale anti-igm-antistoffer, deres fremstilling og anvendelse, og hybridomas for fremstilling av de samme
GB9212074D0 (en) Monoclonal antibody
KR970034239U (ko) 커버의 결합구조
KR970017121U (ko) 자동차 램프 덮개의균열 방지 구조
KR970048674U (ko) 일체형 튜너 커버의 구조